Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cristina Guarducci, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Cristina Guarducci's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Cristina Guarducci has written about over time.
Antineoplastic Agents, Hormonal, 3 publications between 2015 and 2016, average publication date August 2015. Genes, Retinoblastoma, 1 publications between 2018 and 2018, average publication date March 2018. Receptor, ErbB-2, 7 publications between 2015 and 2024, average publication date October 2018. Cyclin-Dependent Kinase 6, 3 publications between 2016 and 2021, average publication date July 2019. Breast Neoplasms, 13 publications between 2015 and 2024, average publication date April 2020. Receptors, Estrogen, 10 publications between 2015 and 2024, average publication date May 2020. Drug Resistance, Neoplasm, 4 publications between 2016 and 2024, average publication date July 2020. Signal Transduction, 3 publications between 2016 and 2024, average publication date August 2020. Cyclin-Dependent Kinase 4, 4 publications between 2016 and 2024, average publication date October 2020. Piperazines, 4 publications between 2016 and 2024, average publication date October 2020. Pyridines, 4 publications between 2016 and 2024, average publication date October 2020. Protein Kinase Inhibitors, 3 publications between 2020 and 2024, average publication date February 2022. Carcinoma, Lobular, 1 publications between 2022 and 2022, average publication date October 2022. Apoptosis, 2 publications between 2023 and 2024, average publication date January 2024. Cell Cycle, 1 publications between 2024 and 2024, average publication date April 2024. Cyclin-Dependent Kinases, 1 publications between 2024 and 2024, average publication date April 2024. Proto-Oncogene Proteins c-myc, 1 publications between 2024 and 2024, average publication date April 2024. Xenograft Model Antitumor Assays, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Guarducci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.